Moreover, HSF1 inhibition by KNK-437 in combination with bortezomib has been demonstrated to play additive effects on apoptosis induction in cells belonging to MM patients with poor prognosis [113]. The gene discussed is HSF1; the disease is Miyoshi myopathy.